Re-Admission of COVID-19 Patients Hospitalized with Omicron Variant-A Retrospective Cohort Study.
COVID-19
Omicron variant
SARS-CoV-2
re-admissions
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
02 Sep 2022
02 Sep 2022
Historique:
received:
01
08
2022
revised:
22
08
2022
accepted:
30
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
10
9
2022
Statut:
epublish
Résumé
In accordance with previous publications, re-admission rates following hospitalization of patients with COVID-19 is 10%. The aim of the current study was to describe the rates and risk factors of hospital re-admissions two months following discharge from hospitalization during the fifth wave due to the dominant Omicron variant. A retrospective cohort study was performed in Rabin Medical Center, Israel, from November 2021 to February 2022. The primary outcome was re-admissions with any diagnosis; the secondary outcome was mortality within two months of discharge. Overall, 660 patients were hospitalized with a diagnosis of COVID-19. Of the 528 patients discharged from a primary hospitalization, 150 (28%) were re-admitted. A total of 164 patients (25%) died throughout the follow-up period. A multi-variable analysis determined that elevated creatinine was associated with a higher risk of re-admissions. Rates of re-admissions after discharge during the Omicron wave were considerably higher compared to previous waves. A discharge plan for surveillance and treatment following hospitalization is of great importance in the management of pandemics.
Identifiants
pubmed: 36079138
pii: jcm11175202
doi: 10.3390/jcm11175202
pmc: PMC9457250
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Emerg Med. 2022 Jan;51:267-279
pubmed: 34781153
N Engl J Med. 2022 Feb 10;386(6):509-520
pubmed: 34914868
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
J Med Virol. 2020 Nov;92(11):2409-2411
pubmed: 32516845
J Intern Med. 2022 Jul;292(1):154-161
pubmed: 35170099
Eur J Intern Med. 2012 Jul;23(5):457-60
pubmed: 22726376
N Engl J Med. 2022 Apr 14;386(15):1397-1408
pubmed: 35172054
Int J Environ Res Public Health. 2020 Aug 12;17(16):
pubmed: 32806775
BMC Geriatr. 2016 May 12;16:102
pubmed: 27175921
MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1695-1699
pubmed: 33180754
BMJ. 2021 Dec 23;375:n3144
pubmed: 34949600
PLoS One. 2021 Aug 5;16(8):e0255427
pubmed: 34351975
Int J Epidemiol. 2021 May 17;50(2):420-429
pubmed: 33683344
BMJ Open. 2018 Mar 30;8(3):e020243
pubmed: 29602852
J Gen Intern Med. 2010 Mar;25(3):211-9
pubmed: 20013068
JBI Database System Rev Implement Rep. 2016 Feb;14(2):106-73
pubmed: 27536797
BMC Geriatr. 2010 May 11;10:22
pubmed: 20459844
Clin Infect Dis. 2022 Aug 24;75(1):e389-e396
pubmed: 35142823
Sci Rep. 2021 Aug 31;11(1):17416
pubmed: 34465827
Brain Behav. 2022 May;12(5):e2552
pubmed: 35398986
Epidemiol Infect. 2018 Aug;146(11):1350-1358
pubmed: 29880077
J Eval Clin Pract. 2015 Aug;21(4):560-6
pubmed: 25756358